However, similarly to classical PKC (α, β), PKCδ was shown either upregulated (hepatocellular cancer) or downregulated (urinary bladder cancer) in various cancer tissues (Tsai et al, 2000; Varga et al, 2004). This evidence concerns the gene PRRT2 and hepatocellular carcinoma.